Hyperbaric oxygen therapy for multiple sclerosis

Ball C M
Record ID 32004000046
Authors' objectives:

This study aims to assess the effects of hyperbaric oxygen therapy compared with other treatments in people with multiple sclerosis.

Authors' recommendations: Conclusions One systematic review has found controlled studies of limited quality, which suggest that hyperbaric oxygen therapy does not improve functional outcomes compared with other treatments or no treatment in people with multiple sclerosis. Adverse effects are likely to include ear barotrauma, claustrophobia and oxygen toxicity, although the frequency of adverse events is unclear.
Authors' methods: Review
Project Status: Completed
URL for project: http://www.wihrd.soton.ac.uk
Year Published: 2002
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: England
MeSH Terms
  • Hyperbaric Oxygenation
  • Multiple Sclerosis
Organisation Name: Wessex Institute for Health Research and Development
Contact Address: Pauline King. Wessex Institute for Health Research and Development, Boldrewood Medical School, Bassett Crescent East, Highfield, Southampton. SO16 7PX Tel. +44 1703 595661 Fax +44 1703 595662
Copyright: Bazian Ltd, Wessex Institute for Health Research and Development
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.